Delivery Order SPE2DB22D9151-SPE2DB25FM8HB
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $26,038.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, awarded on September 12, 2025, with an ultimate completion date of October 3, 2025, carries no set-aside designation. The award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $15,623.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. The contract carries a firm fixed-price structure with no set-aside designation and is scheduled for completion by September 19, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB...
- The Defense Logistics Agency awarded a delivery order valued at $15,623.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, represents a continuation of DMS Pharmaceutical Group's substantial role as a pharmaceutical supplier to the Department of Defense. The award...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,645.39 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the provision of Mirena 52 mg systems. The contract, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, operates under a firm fixed-price structure with no set-aside designation applied. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a $26,038.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $17,760.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which runs through October 2, 2024, is for the delivery of Mirena 52 mg systems, a branded contraceptive device. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
- The Defense Logistics Agency awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $76,117.50, is for the delivery of Mirena 52 mg systems, a contraceptive device, to support the medical supply needs of military healthcare facilities. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 15, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA valued at approximately $500 million...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,920.00 contract, which has no set-aside designation, covers the provision of the Mirena 52 mg intrauterine system to support the recurring medical supply needs of military health facilities worldwide. This delivery order is part of a larger $499,999,999 indefinite delivery contract...
- The Defense Logistics Agency awarded a $7,811.55 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. The award, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at...
- SPE2DB22D9151Indefinite Delivery Contract
- SPE2DB22D9151-SPE2DB25FM8HBDelivery Order
The Defense Logistics Agency has awarded a delivery order valued at $2,603.85 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. The contract is firm fixed-price with an ultimate completion date of August 4, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities nationwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, and medical consumables to military health facilities. The company's contract portfolio with DLA demonstrates expertise across diverse product categories, including contraceptive devices, oncology treatments, vaccines, and specialty medications. As a woman-owned small business registered in the System for Award Management since 2001, the company leverages its status to compete effectively in federal procurement markets while maintaining a robust delivery capability to support DoD healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 7/14/25 |